Edition:
United Kingdom

Karo Pharma AB (KARO.ST)

KARO.ST on Stockholm Stock Exchange

25.75SEK
18 May 2018
Change (% chg)

0.00kr (+0.00%)
Prev Close
25.75kr
Open
25.70kr
Day's High
25.75kr
Day's Low
25.60kr
Volume
747,679
Avg. Vol
434,550
52-wk High
41.68kr
52-wk Low
25.60kr

Latest Key Developments (Source: Significant Developments)

Karo Pharma To Acquire Own Shares
Wednesday, 9 May 2018 

May 9 (Reuters) - KARO PHARMA AB ::HAS DECIDED TO ACQUIRE OWN SHARES.A MAXIMUM OF 10,000,000 SHARES SHALL BE ACQUIRED.  Full Article

Karo Pharma Determines Terms For Rights Issue
Monday, 30 Apr 2018 

April 30 (Reuters) - Karo Pharma AB ::THE TERMS FOR KARO PHARMA'S RIGHTS ISSUE HAVE BEEN DETERMINED.FOR EACH EXISTING SHARE HELD AT RECORD DATE, SHAREHOLDERS WILL RECEIVE ONE (1) SUBSCRIPTION RIGHT.SUBSCRIPTION PRICE HAS BEEN SET AT SEK 24.00 PER SHARE.RIGHTS ISSUE WILL AT MOST RAISE SEK 1,314.7 MILLION BEFORE ISSUE COSTS.ISSUANCE OF A MAXIMUM OF 54,777,594 NEW ORDINARY SHARES.TWO (2) SUBSCRIPTION RIGHTS ENTITLING HOLDER TO SUBSCRIBE FOR ONE (1) ORDINARY NEW SHARE (I.E. A SUBSCRIPTION RATIO OF 1:2).SUBSCRIPTION PERIOD WILL RUN BETWEEN 14 MAY 2018 UNTIL 29 MAY 2018.  Full Article

Karo Pharma: Board Of Directors Resolves On Fully Guaranteed Rights Issue
Wednesday, 4 Apr 2018 

April 4 (Reuters) - KARO PHARMA AB ::THE BOARD OF DIRECTORS OF KARO PHARMA HAS RESOLVED ON A FULLY GUARANTEED RIGHTS ISSUE SUBJECT TO APPROVAL BY THE ANNUAL GENERAL MEETING.IS EXPECTED TO RECEIVE ISSUE PROCEEDS AMOUNTING TO ABOUT SEK 1.3 BILLION BEFORE TRANSACTION COSTS.  Full Article

Karo Pharma Rights Issue Subscribed To 170 Percent
Thursday, 4 Jan 2018 

Jan 4 (Reuters) - KARO PHARMA AB ::RIGHTS ISSUE SUBSCRIBED TO 170 PERCENT WITH PROCEEDS AT ABOUT SEK 794.3 MILLION BEFORE ISSUE COSTS.  Full Article

Karo Pharma: New Issue To Provide Up To SEK 794.3 Ml‍n Before Issue Costs
Friday, 8 Dec 2017 

Dec 8 (Reuters) - Karo Pharma Ab ::SAYS NEW ISSUE TO PROVIDE UP TO SEK 794.3 ML‍N BEFORE ISSUE COSTS.  Full Article

Karo Pharma Chairman Called For Inquiry For Inside Trading
Thursday, 30 Nov 2017 

Nov 30 (Reuters) - Karo Pharma Ab ::CHAIRMAN CALLED IN TO INQUIRY FROM POLICE FOR INSIDE TRADING.BOARD CONCLUDES THE THAT CHAIRMAN HAS ACTED CORRECTLY AND DID NOTHING WRONG, AS PER ITS INVESTIGATION.  Full Article

Karo Pharma signs agreement with Marinomed Biotech
Monday, 27 Nov 2017 

Nov 27 (Reuters) - Karo Pharma Ab ::KARO PHARMA ANNOUNCES AGREEMENT WITH THE AUSTRIAN PHARMACEUTICAL COMPANY MARINOMED BIOTECH AG.‍WILL MARKET A PATENTED PRODUCT FOR COMMON COLD & FLU SYMPTOMS IN SWEDEN, NORWAY AND FINLAND.​.‍AGREEMENT IS LONG TERM (10 YEARS).​.  Full Article

Karo Pharma to carry out new issue
Wednesday, 8 Nov 2017 

Nov 8 (Reuters) - KARO PHARMA AB ::TO CARRY OUT NEW ISSUE WITH PROCEEDS AT ABOUT SEK 800 MILLION BEFORE ISSUE COSTS IF FULLY SUBSCRIBED.  Full Article

Karo Pharma Q3 EBITDA up at SEK ‍34.0​ mln
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - KARO PHARMA AB ::Q3 NET SALES SEK ‍137.1​ MILLION VERSUS SEK 85.2 MILLION YEAR AGO.Q3 EBITDA SEK ‍34.0​ MILLION VERSUS SEK 10.2 MILLION YEAR AGO.  Full Article

Karo Pharma Q3 EBITDA sharply up yr/yr​
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Karo Pharma Ab :Says ‍net sales amounted to MSEK 418.9 (250.8), whereof Q3 MSEK 137.1 (85.2)​.Says ‍EBITDA amounted to MSEK 127.5 (22.8), whereof Q3 MSEK 34.0 (10.2)​.  Full Article

BRIEF-Karo Pharma Determines Terms For Rights Issue

* THE TERMS FOR KARO PHARMA'S RIGHTS ISSUE HAVE BEEN DETERMINED